Commercial Physical & Biological Research Industry - SEC Form 4 Insider Trading Screener

Services Sector - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-09-19
QQuintiles Ims Holdings, Inc.Cpp Investment Board Private Holdings, Inc.10%S - Sale$94.87-6,748,02613,049,669-34%-$640,185,227
2017-09-19
QQuintiles Ims Holdings, Inc.Danhakl John GDirS - Sale$94.87-720,2484,176,443-15%-$68,329,928
2017-09-19
QQuintiles Ims Holdings, Inc.Tpg Group Holdings (Sbs) Advisors, Inc.Dir, 10%S - Sale$94.87-4,877,97428,285,500-15%-$462,773,393
2017-09-19
QQuintiles Ims Holdings, Inc.Connaughton JohnDirS - Sale$94.87-1,030,4296,682,534-13%-$97,756,799
M
2017-09-18
EXELExelixis, Inc.Papadopoulos SteliosDirS - Sale$27.68-200,0001,044,314-16%-$5,535,387
2017-09-20
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.23+3751,008,5000%+$1,586
2017-09-18
INCYIncyte CorpHoppenot HerveCOB , CEOS - Sale$119.45-70,502299,004-19%-$8,421,464
2017-09-18
INCRInc Research Holdings, Inc.Gaenzle Christopher LCAO, GC, SecS - Sale$54.55-4,68255,897-8%-$255,427
2017-09-18
INCRInc Research Holdings, Inc.Rush Gregory SCFOS - Sale$54.48-9,70378,593-11%-$528,600
2017-09-18
INCRInc Research Holdings, Inc.Macdonald AlistairCEOS - Sale$54.60-2,34899,453-2%-$128,201
2017-09-18
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.40+3751,008,1250%+$1,650
2017-09-14
EXELExelixis, Inc.Haley Patrick J.SVP, CommercialS - Sale$27.21-60,64075,046-45%-$1,650,014
2017-09-14
INCYIncyte CorpFlannelly Barry PEVP, GM USS - Sale$124.25-71414,782-5%-$88,715
M
2017-09-12
EXELExelixis, Inc.Willsey LanceDirS - Sale$26.88-100,000468,273-18%-$2,688,000
D
2017-09-12
EXELExelixis, Inc.Senner Christopher J.EVP, CFOS - Sale+OE$26.79-100,000104,798-49%-$2,679,000
DM
2017-09-12
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$26.90-300,000249,718-55%-$8,071,000
2017-09-14
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.58+3751,007,7500%+$1,718
2017-09-11
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.81+3751,007,3750%+$1,804
2017-09-07
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.76+3751,007,0000%+$1,785
2017-09-08
INCYIncyte CorpBaker Bros. Advisors LPDir, 10%P - Purchase$132.00+100,000942,507+12%+$13,200,000
2017-09-08
BASIBioanalytical Systems IncNeff R MatthewDirP - Purchase$1.50+5,00010,000+100%+$7,500
D
2017-09-05
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale+OE$40.81-75,683343,283-18%-$3,088,801
D
2017-09-05
INCYIncyte CorpTrower PaulPrincipal Accounting OfficerS - Sale+OE$138.41-3,00026,706-10%-$415,230
2017-09-05
CRLCharles River Laboratories International IncMolho DavideCorporate EVPS - Sale$108.43-2,66863,566-4%-$289,297
2017-09-05
CRLCharles River Laboratories International IncMolho DavideCorporate EVPS - Sale$108.06-5,88919,217-23%-$636,347
D
2017-09-05
CRLCharles River Laboratories International IncMolho DavideCorporate EVPS - Sale+OE$107.55-5,98225,106-19%-$643,373
D
2017-09-01
QQuintiles Ims Holdings, Inc.Bousbib AriSee RemarksS - Sale+OE$95.65-46,0801,534,061-3%-$4,407,552
D
2017-09-01
INCRInc Research Holdings, Inc.Rush Gregory SCFOS - Sale+OE$58.99-88,73988,296-50%-$5,234,321
AD
2017-08-30
INCRInc Research Holdings, Inc.Rush Gregory SCFOS - Sale+OE$58.26-41,42078,296-35%-$2,413,230
D
2017-09-01
INCYIncyte CorpSiegel Eric H.EVP, GCS - Sale+OE$137.40-1,82021,733-8%-$250,068
D
2017-08-31
INCYIncyte CorpSwain Paula JEVP, HRS - Sale+OE$140.00-20,00035,067-36%-$2,800,000
2017-09-01
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale$41.49-45,775300,966-13%-$1,899,205
D
2017-09-01
INCRInc Research Holdings, Inc.Gaenzle Christopher LCAO, GC, SecS - Sale+OE$58.67-42,60164,824-40%-$2,499,348
2017-09-05
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.90+3751,006,6250%+$1,838
D
2017-08-30
INCRInc Research Holdings, Inc.Rush Gregory SCFOS - Sale+OE$58.26-41,4207,290-85%-$2,413,230
D
2017-08-29
INCYIncyte CorpStein Steven HEVP, Chief Medical OfficerS - Sale+OE$125.00-2,11118,165-10%-$263,875
2017-08-31
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.48+3751,006,2500%+$1,680
2017-08-28
QQuintiles Ims Holdings, Inc.Danhakl John GDirS - Sale$97.33-556,9684,896,691-10%-$54,209,695
2017-08-28
QQuintiles Ims Holdings, Inc.Gillings Dennis B Ph DDirS - Sale$97.33-968,0239,155,906-10%-$94,217,679
2017-08-28
QQuintiles Ims Holdings, Inc.Tpg Group Holdings (Sbs) Advisors, Inc.Dir, 10%S - Sale$97.33-3,772,13433,163,474-10%-$367,141,802
2017-08-28
QQuintiles Ims Holdings, Inc.Connaughton JohnDirS - Sale$97.33-833,9047,834,970-10%-$81,163,876
2017-08-28
QQuintiles Ims Holdings, Inc.Cpp Investment Board Private Holdings, Inc.10%S - Sale$97.33-5,218,24515,299,011-25%-$507,891,786
2017-08-28
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.44+3751,005,8750%+$1,665
D
2017-08-25
QQuintiles Ims Holdings, Inc.Erlinger III James HSee RemarksS - Sale+OE$98.96-10,00017,340-37%-$989,600
D
2017-08-25
QQuintiles Ims Holdings, Inc.Knightly Kevin CSee RemarksS - Sale+OE$99.51-19,33924,351-44%-$1,924,429
D
2017-08-17
USRMU.S. Stem Cell, Inc.Murphy William P JrDirP - Purchase$0.03+1,799,6145,112,600+54%+$49,849
2017-08-24
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.54+3751,005,5000%+$1,703
2017-08-22
XONIntrexon CorpGupta Vinita DDirP - Purchase$17.61+3,0005,839+106%+$52,830
2017-08-22
XONIntrexon CorpShapiro Robert BDirP - Purchase$17.50+2,850126,123+2%+$49,883
2017-08-18
BASIBioanalytical Systems IncDavis Gregory ColeDirP - Purchase$1.70+5,0005,000New+$8,500
2017-08-18
BASIBioanalytical Systems IncNeff R MatthewDirP - Purchase$1.70+5,0005,000New+$8,500
2017-08-22
MEDPMedpace Holdings, Inc.Medpace Limited Partnership10%S - Sale$30.27-2,000,00020,999,997-9%-$60,540,000
2017-08-21
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.07+3751,005,1250%+$1,526
D
2017-08-17
INCRInc Research Holdings, Inc.Macdonald AlistairCEOS - Sale+OE$55.65-8,828101,801-8%-$491,261
2017-08-17
CRLCharles River Laboratories International IncBarbo William DCorporate EVP, CCOS - Sale$99.91-4,00016,924-19%-$399,632
2017-08-18
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$3.81+3751,004,7500%+$1,429
2017-08-17
EXASExact Sciences CorpCarey Thomas D.DirP - Purchase$37.71+2,50060,858+4%+$94,275
2017-08-17
PIRSPieris Pharmaceuticals, Inc.Geraghty James ADirP - Purchase$4.82+10,00010,000New+$48,200
M
2017-08-16
PIRSPieris Pharmaceuticals, Inc.Reine AllanSee RemarksP - Purchase$4.82+65,00065,000New+$313,350
2017-08-14
PRAHPra Health Sciences, Inc.Kkr Pra Investors L.P.10%S - Sale$74.85-9,500,00013,195,984-42%-$711,075,000
2017-08-14
PRAHPra Health Sciences, Inc.Shannon ColinPres, CEOS - Sale$74.85-400,0000-100%-$29,940,000
2017-08-14
PRAHPra Health Sciences, Inc.Baddour LindaEVP, CFOS - Sale$74.85-100,0000-100%-$7,485,000
D
2017-08-14
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale+OE$67.10-2,55211,671-18%-$171,228
2017-08-11
XONIntrexon CorpKindler Jeffrey BDirP - Purchase$18.32+5,44071,762+8%+$99,661
2017-08-14
XONIntrexon CorpLast Andrew J.COOP - Purchase$19.99+2,0002,000New+$39,980
2017-08-11
CASCCascadian Therapeutics, Inc.Myers Scott DunsethPres, CEOP - Purchase$3.73+5,50049,716+12%+$20,543
2017-08-14
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$3.70+3751,004,3750%+$1,388
2017-08-11
XONIntrexon CorpKirk Randal JCEO, 10%P - Purchase$18.85+132,62556,400,1560%+$2,499,981
2017-08-11
XONIntrexon CorpNimrodi NirSVP-Corporate DevelopmentP - Purchase$18.75+3,3697,369+84%+$63,169
2017-08-11
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$3.55+7501,004,0000%+$2,663
D
2017-08-09
QQuintiles Ims Holdings, Inc.Knightly Kevin CSee RemarksS - Sale+OE$90.28-20,00026,826-43%-$1,805,600
2017-08-11
XONIntrexon CorpLehr Donald P.GCP - Purchase$18.33+1,09428,249+4%+$20,053
2017-08-11
XONIntrexon CorpPerez Jeffrey ThomasSVP, IP AffairsP - Purchase$17.89+1,00012,537+9%+$17,890
2017-08-11
XONIntrexon CorpMitchell Dean JDirP - Purchase$18.33+5,00018,103+38%+$91,640
D
2017-08-07
QQuintiles Ims Holdings, Inc.Bousbib AriSee RemarksS - Sale+OE$90.35-92,1601,534,061-6%-$8,326,656
D
2017-08-04
INCYIncyte CorpTrower PaulPrincipal Accounting OfficerS - Sale+OE$125.25-3,00026,706-10%-$375,750
D
2017-08-01
INCYIncyte CorpSiegel Eric H.EVP, GCS - Sale+OE$132.92-1,82021,733-8%-$241,914
D
2017-07-31
EXASExact Sciences CorpElliott Jeffrey ThomasCFOS - Sale+OE$39.41-5,84614,487-29%-$230,391
D
2017-07-20
INCYIncyte CorpStein Steven HEVP, Chief Medical OfficerS - Sale+OE$131.09-6,48518,165-26%-$850,119
2017-07-17
CRLCharles River Laboratories International IncMassaro GeorgeDirS - Sale$101.38-20014,701-1%-$20,276
D
2017-07-17
CRLCharles River Laboratories International IncMassaro GeorgeDirS - Sale+OE$100.81-3,83014,901-20%-$386,103
2017-06-30
HPPIHedgepath Pharmaceuticals, Inc.Hedgepath, LLC10%S - Sale$0.00-2,500,00079,627,069-3%-$0
2017-07-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$100.02-500346,5180%-$50,008
2017-07-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$99.30-5,720336,678-2%-$568,011
2017-07-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$99.07-9,264342,398-3%-$917,818
2017-07-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$98.92-9,516351,662-3%-$941,337
D
2017-07-05
INCYIncyte CorpTrower PaulPrincipal Accounting OfficerS - Sale+OE$126.18-3,00012,148-20%-$378,540
D
2017-07-03
INCYIncyte CorpSiegel Eric H.EVP, GCS - Sale+OE$126.20-1,82018,216-9%-$229,684
D
2017-07-03
EXASExact Sciences CorpCoward D ScottSVP, GCS - Sale+OE$35.21-1,98763,666-3%-$69,962
D
2017-06-30
INCYIncyte CorpGryska David WEVP, CFOS - Sale+OE$129.74-59919,015-3%-$77,714
DM
2017-06-30
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$27.08-2,78532,600-8%-$75,430
DM
2017-07-03
INCRInc Research Holdings, Inc.Gaenzle Christopher LCAO, GC, SecS - Sale+OE$58.32-6,87346,494-13%-$400,846
DM
2017-06-30
INCRInc Research Holdings, Inc.Macdonald AlistairCEOS - Sale+OE$58.38-10,55573,380-13%-$616,159
D
2017-06-29
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$27.00-84632,600-3%-$22,842
DM
2017-06-27
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$27.13-5,05932,600-13%-$137,241
DM
2017-06-23
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$27.18-9,63532,600-23%-$261,918
D
2017-06-22
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$27.25-20932,600-1%-$5,696
D
2017-06-22
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale+OE$100.00-43,154371,518-10%-$4,315,400
D
2017-06-22
CRLCharles River Laboratories International IncMolho DavideCorporate EVPS - Sale+OE$100.00-10,94863,566-15%-$1,094,800
DM
2017-06-20
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$27.38-2,15932,600-6%-$59,113

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top